Prognostic Factors in Patients Receiving An Allogeneic Stem Cell Transplantation for Relapsed AML. Results of the Prospective AML 295 and 01/99 Studies

被引：0
|
作者：
Krauter, Juergen [1 ]
Heil, Gerhard [2 ]
Hoelzer, Dieter [3 ]
Martin, Hans [3 ]
Ottmann, Oliver G. [3 ]
Finke, Juergen [4 ]
Luebbert, Michael [5 ]
Heit, Wolfgang [6 ]
Fiedler, Walter [7 ]
Kanz, Lothar [8 ]
Schlimok, Guenter [9 ]
Kirchner, Hartmut [10 ]
Raghavachar, Aruna [11 ]
Brugger, Wolfram [12 ]
Doehner, Hartmut [13 ]
Ganser, Arnold [1 ]
机构：
[1] Hannover Med Sch, Dept Hematol Hemostaseol Oncol & Stem Cell Transp, D-3000 Hannover, Germany
[2] Krankenhaus Ludenscheid, Ludenscheid, Germany
[3] JW Goethe Univ Hosp, Frankfurt, Germany
[4] Univ Med Ctr Freiburg, Freiburg, Germany
[5] Univ Freiburg, Med Ctr, D-7800 Freiburg, Germany
[6] Kliniken Essen Sud, Essen, Germany
[7] Univ Hosp Eppendorf, Dept Hematol & Oncol, Hamburg, Germany
[8] Univ Tubingen, Tubingen, Germany
[9] Klinikum Augsburg, Med Klin 2, Augsburg, Germany
[10] Klinik Hannover, Hannover, Germany
[11] HELIOS Klinikum Wuppertal, Med Klin 1, Wuppertal, Germany
[12] Hosp Villingen Schwenningen, Schwenningen, Germany
[13] Univ Ulm, Ulm, Germany
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：134 / 134
页数：1
相关论文
共 50 条
  • [1] Impact of allogeneic stem cell transplantation on prognosis of patients with high-risk AML: results of the AML SHG 295 and 01/99 trials
    Wagner, K.
    Heil, G.
    Zucknick, M.
    Hoelzer, D.
    Ottmann, O. G.
    Martin, H.
    Luebbert, M.
    Finke, J.
    Heit, W.
    Fiedler, W.
    Kanz, L.
    Schlimok, G.
    Kirchner, H.
    Raghavachar, A.
    Brugger, W.
    Ganser, A.
    Krauter, J.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S8 - S8
  • [2] Haemophagocytic syndrome in relapsed AML patients after allogeneic stem cell transplantation
    Keklik, C. P. M.
    Akyol, G.
    Canoz, O.
    Sivgin, S.
    Kaynar, L.
    Eser, B.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S528 - S529
  • [3] Allogeneic stem cell transplantation (SCT) for myelodysplastic syndrome and secondary AML.
    Schwerdtfeger, R
    Braeuninger, S
    Prumbaum, M
    Kreissig, C
    Baurmann, H
    BLOOD, 2000, 96 (11) : 364B - 364B
  • [4] Allogeneic stem cell transplantation with reduced intensity conditionning regimen (RIC) for adult patients with AML: Same results in secondary and de novo AML.
    Milpied, Noel-Jean
    Tabrizi, Reza
    Guillaume, Thierry
    Chevallier, Patrice
    Pigneux, Arnaud
    Boiron, Jean Michel
    Moreau, Philippe
    Mahe, Beatrice
    Leguay, Thibaut
    Bouabdallah, Krimo
    Morineau, Nadine
    Delaunay, Jacques
    Melot, Cyril
    Saulquin, Beatrice
    Marit, Gerald
    Harousseau, Jean Luc
    BLOOD, 2006, 108 (11) : 855A - 856A
  • [5] Indications for allogeneic stem cell transplantation in patients with AML
    Passweg, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 227 - 227
  • [6] Tailored strategy for AML patients receiving allogeneic peripheral blood stem cell transplantation
    Sohn, Sang Kyun
    Kim, Jong Gwang
    Kim, Dong Hwan
    JOURNAL OF CLINICAL APHERESIS, 2006, 21 (03) : 207 - 213
  • [7] Outcomes Of Allogeneic Hematopoietic Stem Cell Transplantation In AML Patients Registered In Prospective Studies: The JALSG Experience
    Ishiyama, Ken
    Ohtake, Shigeki
    Sakamaki, Hisashi
    Miyazaki, Yasushi
    Miyawaki, Shuichi
    Ohnishi, Kazunori
    Naoe, Tomoki
    BLOOD, 2013, 122 (21)
  • [8] Successful treatment of relapsed AML after allogeneic stem cell transplantation with azacitidine
    Graef, Thorsten
    Kuendgen, Andrea
    Fenk, Roland
    Zohren, Fabian
    Haas, Rainer
    Kobbe, Guido
    LEUKEMIA RESEARCH, 2007, 31 (02) : 257 - 259
  • [9] IMPROVED OUTCOME OVER TIME AFTER SECOND ALLOGENEIC STEM CELL TRANSPLANTATION IN RELAPSED AML. AN ANALYSIS OF 1540 PATIENTS ON BEHALF OF THE ALWP OF EBMT
    Schmaelter, Ann-Kristin
    Ngoya, Maud
    Galimard, Jacques-Emmanuel
    Bazarbachi, Ali
    Finke, Juergen
    Kroeger, Nicolaus
    Stoelzel, Friedrich
    Stelljes, Matthias
    Valerius, Thomas
    Tischer, Johanna
    Schroeder, Thomas
    Dreger, Peter
    Blau, Igor-Wolfgang
    Savani, Bipin
    Giebel, Sebastian
    Esteve, Jordi
    Nagler, Arnon
    Schmid, Christoph
    Ciceri, Fabio
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 341 - 342
  • [10] Pretransplantation risk factors for positive MRD after allogeneic stem cell transplantation in AML patients: a prospective study
    Li, Si-Qi
    Yu, Chun-Zi
    Xu, Lan-Ping
    Wang, Yu
    Zhang, Xiao-Hui
    Chen, Huan
    Chen, Yu-Hong
    Wang, Feng-Rong
    Sun, Yu-Qian
    Yan, Chen-Hua
    Lv, Meng
    Mo, Xiao-Dong
    Liu, Yan-Rong
    Liu, Kai-Yan
    Zhao, Xiao-Su
    Zhao, Xiang-Yu
    Huang, Xiao-Jun
    Chang, Ying-Jun
    BONE MARROW TRANSPLANTATION, 2024, : 277 - 285
12345